Alkermes (ALKS) Tops Q2 EPS by 2c; updates guidance
Tweet
Share
E-mail
Get Alerts ALKS Hot Sheet
Price: $46.11 +1.56%
EPS Growth %: -108.2%
Financial Fact:
Royalty revenues: 9.44M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -108.2%
Financial Fact:
Royalty revenues: 9.44M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q2 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $496.01 million versus the consensus estimate of $458.98 million.
GUIDANCE:
Alkermes sees FY2026 revenue of $1.73-1.84 billion, versus the consensus of $1.81 billion.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Microsoft plans data center push to triple its computing power - Bloomberg
- JPMorgan Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- UBS Upgrades SD Guthrie (SDG:MK) to Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
